Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - December 14, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities, is pleased to announce that its management team, including Chief Executive Officer Janet Qi and Chief Scientific Officer Dr. Alan Kozikowski, will be att
Related Keywords
United States , San Francisco , California , Toronto , Ontario , Canada , Boston , Massachusetts , Purminds Neuropharma , Kristina Spionjak , Alan Kozikowski , Janet Qi , Massachusetts Newsfile Corp , Health Canada Controlled Drugs , Minds Neuropharma , Chief Scientific Officer , Healthcare Meeting , Ontario Neurolab , Production Facility , Canada Controlled Drugs , Substances Dealer , Neurodegenerative Disorders , Neurological Disorders , Neuropharma , Proprietary Formulation ,
comparemela.com © 2020. All Rights Reserved.